Academic Journal
1043P Clinical predictors of benefit from pembrolizumab (pembro) or pembro-chemotherapy (CHT) in advanced non-small cell lung cancer (NSCLC)
| العنوان: | 1043P Clinical predictors of benefit from pembrolizumab (pembro) or pembro-chemotherapy (CHT) in advanced non-small cell lung cancer (NSCLC) |
|---|---|
| المؤلفون: | Zullo, L., Cella, E., Favero, D., Parisi, F., Dellepiane, C., Rossi, G., Bennicelli, E., Barletta, G., Zinoli, L., Pronzato, P., Del Mastro, L., Genova, C. |
| المصدر: | Annals of Oncology ; volume 33, page S1031 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2022.07.1169 |
| الاتاحة: | http://dx.doi.org/10.1016/j.annonc.2022.07.1169 https://api.elsevier.com/content/article/PII:S0923753422030204?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753422030204?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| رقم الانضمام: | edsbas.75D9C5AC |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2022.07.1169 |
|---|